Zipsor approved for mild to moderate acute pain relief

Zipsor approved for mild to moderate acute pain relief
Zipsor approved for mild to moderate acute pain relief
The FDA has approved Zipsor (diclofenac potassium liquid filled capsules, from Xanodyne), a nonsteroidal antiinflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults ≥18 years old. This approval was based on the demonstration of safety and efficacy of Zipsor in two well controlled post-surgical bunionectomy clinical trials. Zipsor patients, at baseline, had an average pain intensity of 6.9 (on a 0 to 10 numeric pain rating scale).

For more information call (859) 371-6383 or visit www.xanodyne.com.